Peer-reviewedCC BYCureus
Selective Serotonin Reuptake Inhibitor-Associated Bruxism: Neuropharmacologic Mechanisms and Clinical Implications
- 1Sleep Medicine, Southwest Healthcare Medical Education Consortium, Temecula, USA
Related
- Real-world pharmacovigilance analysis of adverse events associated with selective serotonin reuptake inhibitor antidepressants in children and adolescents
- Aripiprazole versus Bupropion Augmentation in Patients with Anxious Depression Resistant to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-label, Multicenter Study
- Selective serotonin reuptake inhibitors and tricyclic antidepressants differentially affect heart failure risk in patients with kidney failure.
- Potential drug-drug interaction risks of selective serotonin reuptake inhibitors in outpatients: a retrospective analysis using two screening databases
- Clinical Severity and Serotonin Toxicity in Antidepressant Self-Poisoning: Implications for Clinical Risk Assessment
BibTeX
@article{pham2026selective,
title = {{Selective Serotonin Reuptake Inhibitor-Associated Bruxism: Neuropharmacologic Mechanisms and Clinical Implications}},
author = {Binh Pham},
journal = {Cureus},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13653650},
note = {CC BY},
}
RIS
TY - JOUR
TI - Selective Serotonin Reuptake Inhibitor-Associated Bruxism: Neuropharmacologic Mechanisms and Clinical Implications
AU - Binh Pham
PY - 2026
DA - 2026/10/16
JO - Cureus
UR - https://europepmc.org/article/PMC/PMC13653650
SN - 2168-8184
ER -